Drugs / ACWY Vax
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00901940 Comparator | Jun 2009 → Oct 2010 | bacterial infectious disease with sepsis, meningitis | University of Oxford | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACWY Vax | “The MenACWY Plain Polysaccharide Vaccine, which is already licensed and is used as a travel vaccine, is known as the MenACWY plain polysaccharide (ACWY Vax).” NCT00901940 ↗ |
| Known as | MenACWY plain polysaccharide | “The MenACWY Plain Polysaccharide Vaccine, which is already licensed and is used as a travel vaccine, is known as the MenACWY plain polysaccharide (ACWY Vax).” NCT00901940 ↗ |
| Modality | Vaccine | “meningococcal plain polysaccharide vaccine” NCT00901940 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT00901940 ↗ |